Skip to content
healthcare.dev

Nasal Decongestant Maximum Strength

NDC 63868-802, Pseudoephedrine HCl, tablet, film coated, from CHAIN DRUG MARKETING ASSOCIATION INC.

Product NDC
63868-802
Status
Listed
Labeler
CHAIN DRUG MARKETING ASSOCIATION INC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63868-802 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PSEUDOEPHEDRINE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
63868-802-24638680802241 BLISTER PACK in 1 CARTON (63868-802-24) / 24 TABLET, FILM COATED in 1 BLISTER PACK
63868-802-48638680802482 BLISTER PACK in 1 CARTON (63868-802-48) / 24 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63868-802 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63868-802 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63868-802. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.